Among patients in the real world with unresectable or metastatic urothelial carcinoma, Padcev significantly improved overall ...

Final results were consistent with previously conducted research in patients with advanced renal cell carcinoma treated with ...

Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...

When done right, Yoga reduces inflammation, increases immunity, and even changes destructive behaviours that lead to cancer ...

Results from a post-hoc exploratory subgroup analysis from the NIAGARA Phase III trial showed AstraZeneca’s (AZN) IMFINZI, ...

Several important steps should be taken and/or considered after the identification of an oral cavity lesion: Perform a ...

Enfortumab vedotin with or without pembrolizumab offers disease control benefits for patients with upper tract urothelial cancer, said Evangelia Vlachou, MD, of Johns Hopkins Medicine.

She noted the survival benefit with the combination was achieved even though 38% of patients in the enzalutamide-alone arm ...

New results uphold previous findings regarding the efficacy of cabozantinib, nivolumab, and ipilumumab arm for advanced renal ...

Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) or chemoradiotherapy (CRT) is the standard of care for patients with muscle invasive bladder cancer (MIBC). Mutations ...

Dr. Axel Heidenreich presented the final results of the COTRIMS (Cologne trial of retroperitoneal lymphadenectomy in metastatic seminoma) trial. Clinical stage (CS) IIA/B seminoma accounts for only 10 ...